Advertisement

Showing posts matching the search for BiologicsShow All
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

webmaster Wednesday, July 05, 2023

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,00…

Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab
inwill

Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab

webmaster Thursday, December 26, 2024

Mankind , Cancer , Innovent , India , Pharma , Sintilimab , Market , Across , I…

Mankind Pharma Completes Landmark Acquisition of BSV
inPharma

Mankind Pharma Completes Landmark Acquisition of BSV

webmaster Thursday, October 24, 2024

Mankind Pharma Completes Landmark Acquisition of BSV Expands high entry barri…

Syngene International announces third year of STEM scholarship and mentorship program for women in collaboration with RICH
inWomen

Syngene International announces third year of STEM scholarship and mentorship program for women in collaboration with RICH

webmaster Saturday, July 12, 2025

Syngene International announces third year of STEM scholarship and mentorship …

That is All